Vincent Woo

机构：University of Manitoba · ORCID：0000-0003-1745-6381

发表论文 190 篇 · 总被引 24242 次 · h-index 51

代表论文

• Once-weekly insulin icodec versus once-daily insulin degludec as part of a basal-bolus regimen in individuals with type 1 diabetes (ONWARDS 6): a phase 3a, randomised, open-label, treat-to-target trial (2023 · The Lancet · 被引 108)
• 2022 Canadian Cardiovascular Society Guideline for Use of GLP-1 Receptor Agonists and SGLT2 Inhibitors for Cardiorenal Risk Reduction in Adults (2022 · Canadian Journal of Cardiology · 被引 57)
• Add-On Treatment With Zilebesiran for Inadequately Controlled Hypertension (2025 · JAMA · 被引 36)
• Kidney and Cardiovascular Effects of Canagliflozin According to Age and Sex: A Post Hoc Analysis of the CREDENCE Randomized Clinical Trial (2023 · American Journal of Kidney Diseases · 被引 34)
• Management of type 2 diabetes, obesity, or nonalcoholic steatohepatitis with high‐dose GLP‐1 receptor agonists and GLP‐1 receptor‐based co‐agonists (2023 · Obesity Reviews · 被引 27)
• Remission of Type 2 Diabetes Following a Short-term Intensive Intervention With Insulin Glargine, Sitagliptin, and Metformin: Results of an Open-label Randomized Parallel-Design Trial (2021 · Diabetes Care · 被引 23)